國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 915037      Online Users : 1428
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    Periodical Articles [327/330]
    Books/Book Section [1/1]
    Conference Papers/Meeting Abstract [115/179]

    Community Statistics


    Item counts issued in 3 years:74(14.51%)
    Items With Fulltext:443(86.86%)

    Download counts of the item
    Download times greater than 0:443(100.00%)
    Download times greater than 100:426(96.16%)
    Total Bitstream Download Counts:178127(3.32%)

    Last Update: 2024-12-01 08:26

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 276-300 of 510. (21 Page(s) Totally)
    << < 7 8 9 10 11 12 13 14 15 16 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2016-02 Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells RNA. 2016 Feb;22(2):303-315.
    2016-02 Expanded analyses of NAPOLI-1: Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy Oncology Research and Treatment. 2016 Feb;39(Suppl. 1):170.
    2016-02 Results of Phase II trial of AUY922, a novel heat shock protein inhibitor in patients with metastatic gastrointestinal stromal tumor (GIST) and imatinib and sunitinib therapy Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 134.
    2016-02 Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC) Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 369.
    2016-02 A randomized, open-label phase II study of nanoliposomal irinotecan (nal-IRI)-containing regimens versus nab-paclitaxel plus gemcitabine in patients with previously untreated metastatic pancreatic adenocarcinoma (mPAC) Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract TPS482.
    2016-02 Phase III study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 417.
    2016-02 Phase I dose-escalation study of sorafenib plus S-1 in refractory solid tumors Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 745.
    2016-01 Investigating the association between periodontal disease and risk of pancreatic cancer Pancreas. 2016 Jan;45(1):134-141.
    2016-01 S-1 with leucovorin for gastric cancer: How far can it go? Lancet Oncology. 2016 Jan;17(1):12-14.
    2016-01 A phase II study of sequential capecitabine plus oxaliplatin followed by docetaxel plus capecitabine in patients with unresectable gastric adenocarcinoma: The TCOG 3211 clinical trial Medicine. 2016 Jan;95(3):Article number e2565.
    2015-12-21 G9a orchestrates PCL3 and KDM7A to promote histone H3K27 methylation Scientific Reports. 2015 Dec 21;5:Article number 18709.
    2015-12 A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial Journal of Gastroenterology and Hepatology. 2015 Dec;30(Suppl. S4):99.
    2015-10 Epigenetic regulation in the carcinogenesis of cholangiocarcinoma International Journal of Biochemistry and Cell Biology. 2015 Oct;67:110-114.
    2015-10 Changes in DNA methylation are associated with the development of drug resistance in cervical cancer cells Cancer Cell International. 2015 Oct;15:Article number 98.
    2015-09 AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-kappaB activation Leukemia and Lymphoma. 2015 Sep;56(9):2674-2682.
    2015-09 The safety and efficacy of everolimus for the treatment of progressive gastroenteropancreatic neuroendocrine tumors: A multi-institution observational study in Taiwan European Journal of Cancer. 2015 Sep;51(Suppl. 3):S459.
    2015-09 Expression of the Helicobater pylori CagA protein is closely associated with Helicobater pylori-dependence of early-stage high-grade gastric lymphoma European Journal of Cancer. 2015 Sep;51(Suppl. 3):S662.
    2015-08 Primary gastrointestinal stromal tumor of the liver in an anorectal melanoma survivor: A case report Oncology Letters. 2015 Aug;10(4):2366-2370.
    2015-08 The association between periodontal disease and pancreatic cancer Cancer Research. 2015 Aug;75:Abstract number 871.
    2015-07 Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review Cancer Research and Treatment. 2015 Jul;47(3):343-361.
    2015-06 Helicobacter pylori CagA translocation is closely associated with the expression of CagA-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphoma American Journal of Surgical Pathology. 2015 Jun;39(6):761-766.
    2015-06 Comprehensive analysis of the incidence and survival patterns of lung cancer by histologies, including rare subtypes, in the era of molecular medicine and targeted therapy: A nation-wide cancer registry-based study from Taiwan Medicine. 2015 Jun;94(24):Article number e969.
    2015-05 A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer Annals of Oncology. 2015 May;26(5):943-949.
    2015-05 Heterogeneous cell origin of helicobater pylori-dependent high-grade gastric lymphomas Journal of Clinical Oncology. 2015 May;33(15, Suppl.):e19520.
    2015-05 Randomized, phase III trial of adjuvant adeforvir vs. therapeutic lamivudine in post-operative BCLC stage 0 or A HBV-related HCC: The Taiwan Cooperative Oncology Group T1206 study Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4101.

    Showing items 276-300 of 510. (21 Page(s) Totally)
    << < 7 8 9 10 11 12 13 14 15 16 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback